Open Access
Volume 18, Number 5, Septembre-Octobre 2011
Lipids and Brain II. Actes des Journées Chevreul 2011 (Deuxième partie)
Page(s) 237 - 241
Section Signalling Mechanisms and Metabolism of Omega-3 PUFA in the Brain
Published online 15 September 2011
  • Akbar M, Kim HY. Protective effects of docosahexaenoic acid (DHA) in staurosporine-induced apoptosis: Involvement of wortmanin-sensitive pathway. J Neurochem 2002; 82: 655–665. [CrossRef] [PubMed] [Google Scholar]
  • Akbar M, Calderon F, Wen Z, Kim HY. Docosahexaenoic Acid: A positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci USA 2005; 102: 10858–10863. [CrossRef] [Google Scholar]
  • Alessi DR, Cohen P. Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 1998; 8: 55–62. [CrossRef] [PubMed] [Google Scholar]
  • Birch EE, Garfield S, Hoffman DR, Uauy RD, Birch DG. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 2000; 42: 174–181. [CrossRef] [PubMed] [Google Scholar]
  • Calderon F, Kim HY. Detection of intracellular phosphatidylserine in living cells. J Neurochem 2008; 104: 1271–1279. [CrossRef] [PubMed] [Google Scholar]
  • Cao D, Kevala K, Jun S, Lovinger D, Kim HY. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J Neurochem 2009; 111: 510–521. [CrossRef] [PubMed] [Google Scholar]
  • Gamoh S, Hashimoto M, Sugioka K, et al. Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. Neuroscience 1999; 93: 237–241. [CrossRef] [PubMed] [Google Scholar]
  • Garcia M, Ward G, Ma YC, Salem Jr N, Kim HY. Effect of docosahexaenoic acid on the synthesis of phosphatidylserine in rat brain microsomes and C6 glioma cells. J Neurochem 1998; 70: 24–30. [CrossRef] [PubMed] [Google Scholar]
  • Guo M, Stockert L, Akbar M, Kim HY. Neuronal specific increase of phosphatidylserine by docosahexaenoic acid. J. Mol. Neurosci 2007; 33: 67–73. [CrossRef] [PubMed] [Google Scholar]
  • Hamilton J, Greiner R, Salem Jr N, Kim HY. N-3 fatty acid deficiency decreases phosphatidylserine accumulation selectively in neuronal tissues. Lipids 2000; 35: 863–9. [CrossRef] [PubMed] [Google Scholar]
  • Huang BX, Akbar M, Kevala K, Kim HY. Phosphatidylserine as a critical modulator of Akt activation. J. Cell Biol 2011; 192: 979–992. [CrossRef] [PubMed] [Google Scholar]
  • Improta-Brears T, Ghosh S, Bell RM. Mutational analysis of Raf-1 cysteine rich domain: requirement for a cluster of basic aminoacids for interaction with phosphatidylserine. Mol Cell Biochem 1999; 198: 171–178. [CrossRef] [PubMed] [Google Scholar]
  • Kevala HJ, Kim HY. Determination of substrate preference in phosphatidylserine decarboxylation by liquid chromatography-electrospray mass spectrometry. Anal Biochem 2001; 292: 130–138. [CrossRef] [PubMed] [Google Scholar]
  • Kim HY, Akbar M, Lau A, Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n–3): Role of phosphatidylserine in antiapoptotic effect. J Biol Chem 2000; 275: 35215–35223. [CrossRef] [PubMed] [Google Scholar]
  • Kim HY, Bigelow J, Kevala JH. Substrate preference in phosphatidylserine biosynthesis for docosahexaenoic acid containing species. Biochemistry 2004; 43: 1030–1036. [CrossRef] [PubMed] [Google Scholar]
  • Kim HY. Novel metabolism of docosahexaenoic acid in neural cells. J Biol Chem 2007; 282: 18661–18665. [CrossRef] [PubMed] [Google Scholar]
  • Kim HY. Biochemical and biological functions of docosahexaenoic acid in the nervous system: modulation by ethanol. Chem Phys Lipids 2008; 153: 34–36. [CrossRef] [PubMed] [Google Scholar]
  • Kim HY, Akbar M, Kim YS. Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids 2010; 82: 165–172. [CrossRef] [PubMed] [Google Scholar]
  • Kim HY, Lee J, Moon HS, et al. Metabolism of docosahexaenoic acid to N -docosahexaenoylethanolamide in hippocampal neurodevelopment. Biochem J 2011; 435: 327–336. [CrossRef] [PubMed] [Google Scholar]
  • Kim HY, Spector AA, Xiong ZM. A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. Prostaglandins Other Lipid Med. (In Press). 2012. [Google Scholar]
  • Lands WEM. Metabolism of glycerolipids. J Biol Chem 1960; 235: 2233–7. [PubMed] [Google Scholar]
  • Moriguchi T, Greiner RS, Salem Jr N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 2000; 75: 2563–2573. [CrossRef] [PubMed] [Google Scholar]
  • Salem Jr N, Litman B, Kim HY, Gawrisch K. Mechanism of action of docosahexaenoic acid in the nervous system. Lipids 2001; 36: 945–959. [CrossRef] [PubMed] [Google Scholar]
  • Stokoe D, Macdonald SG, Cadwallader K, Symons K, Hancock JF. Activation of Raf as a result of recruitment to the plasma membrane. Science 1994; 264: 1463–67; Correction (1994) Science 266: 1792–3. [CrossRef] [PubMed] [Google Scholar]
  • Vance JE. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids. J Lipid Res 2008; 49: 1377–1387. [CrossRef] [PubMed] [Google Scholar]
  • Wen Z, Kim HY. Inhibition of phosphatidylserine biosynthesis by ethanol in developing rat brain. J Neurosci Res 2007; 85: 1568–1578. [CrossRef] [PubMed] [Google Scholar]
  • Willatts P, Forsyth JS, Di Modugno MK, Varma S, Colvin M. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 1998; 352: 688–691. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.